Medical News

RSS

USPTO grants Tethys key patent for PreDx Diabetes Risk Score test

Tethys Bioscience, Inc., a privately held company, announced today that the United States Patent and Trademark Office has granted the Company US Patent 7,723,050. The patent is directed to the company's groundbreaking PreDx™ Diabetes Risk Score (DRS) test and relates to proprietary methods for assessing the risk of developing a diabetic condition.

24 Jun 2010

Zetiq completes clinical trial of CellDetect technology for early identification of cervical cancer

Zetiq Technologies Ltd., a subsidiary of Bio-Light Ltd., reports the successful completion of another clinical trial to validate the effectiveness of the company's technology for early identification and diagnosis of cervical cancer, in conventional cytological smears.

24 Jun 2010

MonoSol Rx, Midatech collaborate to develop peptides for therapeutic delivery utilizing pharmaceutical films

MonoSol Rx, the developer of PharmFilm® drug delivery technology, today announced the expansion of its agreement with Midatech Group (Oxford, UK) to develop nanoparticle-based proteins and peptides for therapeutic delivery utilizing pharmaceutical films. Under the terms of the expanded agreement, MonoSol Rx has made an equity investment in Midatech and Keith Kendall, Executive Vice President and Chief Financial Officer of MonoSol Rx, will join the Midatech Board of Directors.

24 Jun 2010

Nektar commences dosing in Phase 1 study of NKTR-102 in combination with 5-FU/leucovorin

Nektar Therapeutics announced today that the first patients have been dosed in a new Phase 1 dose-escalation clinical study to evaluate NKTR-102, the company's lead oncology compound, in combination with 5-fluorouracil (5-FU)/leucovorin in refractory solid tumor cancers. The study is being conducted at University Hospitals Case Medical Center of the Case Comprehensive Cancer Center in Cleveland, Ohio.

24 Jun 2010

Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Merck today announced plans to initiate a Phase II investigational proof-of-concept clinical study to evaluate its oral antifungal agent posaconazole for the treatment of chronic Chagas disease. Chagas disease results from infection with the parasite Trypanosoma cruzi that is spread by biting insects. The disease is estimated to affect approximately eight million people in Latin America, of whom approximately 30-40 percent will develop serious cardiac disease, digestive disease, or both as a result of this infection.

24 Jun 2010

Zilog launches ZMOTION Detection and Control solutions

Zilog, an IXYS company, and a trusted supplier of application specific, embedded micro controller (MCU) system-on-chip (SoC) solutions for industrial and consumer markets, today introduced its latest sensing and control technology for motion detection applications, including intrusion, security alarm industry, customer sensing and lighting control, medical patient monitoring, and other energy management applications.

24 Jun 2010

MDS Nordion, Guerbet, Cyceron collaborate to develop new PET radiotracers for cancer diagnostics

MDS Nordion, a leading provider of products and services to the global health science market, Guerbet, a pharmaceutical group specialized in medical imaging, and Cyceron, a biomedical imaging centre in France, announced today they have entered into an agreement to develop new Positron Emission Tomography (PET) radiotracers for cancer diagnostics.

24 Jun 2010

AGTC, Icagen complete agreement for purchase and sale of patent rights

AGTC, a privately held company, and Icagen, Inc. today announced the completion of an agreement for the purchase and sale of certain patent rights between the companies. Icagen is transferring its rights to patents relating to the ion channel gene CNGB3, which has been linked to certain disorders of the eye. Under the terms of the agreement, Icagen has assigned ownership of the patents to AGTC, which intends to use the patented technology for gene therapy as a potential treatment for Achromatopsia, a severe form of daytime blindness.

24 Jun 2010

Boston Scientific launches SCS lead splitters for use with Precision Plus Spinal Cord Stimulator System

Boston Scientific Corporation today announced U.S. Food and Drug Administration approval and launch of two spinal cord stimulation (SCS) lead splitters for use with its Precision Plus™ Spinal Cord Stimulator System, the world's first rechargeable SCS device for the management of chronic pain of the trunk, back and/or limbs.

24 Jun 2010

Infinity commences enrollment in IPI-493 Phase 1 clinical trial for advanced hematologic malignancies

Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.

24 Jun 2010

Cyanotech's revenues for fiscal 2010 increase 13%

Cyanotech Corporation, a world leader in microalgae-based, high-value nutrition and health products, today announced financial results for fiscal year 2010, ended March 31, 2010.

24 Jun 2010

St. Luke's joins Dr. John Goss in celebration of his 1,000th liver transplantation procedure

St. Luke's Episcopal Hospital (St. Luke's) joins John Goss, M.D., in celebrating his milestone as he recently performed his 1,000th liver transplantation procedure. The largest liver transplant program in Houston's world-renowned Texas Medical Center, St. Luke's performs approximately 75 liver transplants annually. Additionally, St. Luke's liver transplant survival rate is the highest in the nation, with a one-year adult patient survival rate of 96.5 percent compared to the national expected survival rate of 89.38 percent.

24 Jun 2010

BCBST achieves certification for implementation of CAQH CORE Phase II rules

CAQH announced today that BlueCross BlueShield of Tennessee has achieved certification for its implementation of the CAQH Committee on Operating Rules for Information Exchange Phase II rules. The certification will benefit more than 3 million insured members of the Tennessee health plan.

24 Jun 2010

LTCFP announces publication of revised guidebook, Long Term Care Insurance at the Worksite

Many companies seem conflicted by a key part of the recent Health Reform legislation, the CLASS Act, which will offer a form of long term care insurance for working people who may become disabled. "CLASS" stands for Community Living Assistance Services and Supports; and the program, a legacy of the late Senator Edward Kennedy, is intended to offer new choice and security for millions now at risk. But, "we find that those who manage employees or employee benefits don't know how to react," says Denise Gott, Chairman of the Board of LTC Financial Partners LLC, one of the nation's most experienced long term care insurance agencies.

24 Jun 2010

Emergent BioSolutions completes sales, deliveries of BioThrax to allied international governments

Emergent BioSolutions Inc. announced today that it has completed separate international sales and deliveries of BioThrax® (Anthrax Vaccine Adsorbed) to governments of several allied nations. The company's international sales efforts have resulted in these sales of an undisclosed number of BioThrax doses for aggregate revenue of approximately $2.3 million in the second quarter.

24 Jun 2010

International Stem Cell congratulates ACT on the issuance of its recent patent

International Stem Cell Corporation, www.intlstemcell.com, a California-based biotechnology company focused on therapeutic and research products, congratulates Advanced Cell Technology, Inc. on the issuance of its recent patent, U.S. Patent Number 7,736,896, covering a method for producing retinal pigment epithelial cells.

24 Jun 2010

Premier healthcare alliance recognizes winners of Pinnacle and Performance Awards

The Premier healthcare alliance has recognized the winners of its fifth annual awards for suppliers exceeding operational and quality expectations.

24 Jun 2010

Inhalation of gaseous hydrogen sulfide can reduce or prevent lung injury associated with mechanical ventilation

A study appearing in the July 2010 issue of Anesthesiology is the first to show that inhalation of gaseous hydrogen sulfide can reduce or even prevent lung injury in critical care situations that require mechanical ventilation.

24 Jun 2010

Individuals get involved in alcohol or drug related accidents during summer holidays

As the days grow longer and hotter, some chemical dependency professionals have their own name for summer: substance abuse season, because that's when individuals who abuse or are addicted to alcohol, prescription medications and drugs get involved in alcohol or drug related accidents during the summer holidays.

24 Jun 2010

Palatin announces completion of patient dosing, database lock in bremelanotide study for ED

Palatin Technologies, Inc. today announced the completion of patient dosing and database lock in a double-blind, placebo-controlled, multiple dose, crossover study of bremelanotide, its subcutaneously administered melanocortin agonist for treatment of erectile dysfunction (ED). Palatin expects to report top-line data in the next calendar quarter.

24 Jun 2010

Medical News

USPTO grants Tethys key patent for PreDx Diabetes Risk Score test

Zetiq completes clinical trial of CellDetect technology for early identification of cervical cancer

MonoSol Rx, Midatech collaborate to develop peptides for therapeutic delivery utilizing pharmaceutical films

Nektar commences dosing in Phase 1 study of NKTR-102 in combination with 5-FU/leucovorin

Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Zilog launches ZMOTION Detection and Control solutions

MDS Nordion, Guerbet, Cyceron collaborate to develop new PET radiotracers for cancer diagnostics

AGTC, Icagen complete agreement for purchase and sale of patent rights

Boston Scientific launches SCS lead splitters for use with Precision Plus Spinal Cord Stimulator System

Infinity commences enrollment in IPI-493 Phase 1 clinical trial for advanced hematologic malignancies

Cyanotech's revenues for fiscal 2010 increase 13%

St. Luke's joins Dr. John Goss in celebration of his 1,000th liver transplantation procedure

BCBST achieves certification for implementation of CAQH CORE Phase II rules

LTCFP announces publication of revised guidebook, Long Term Care Insurance at the Worksite

Emergent BioSolutions completes sales, deliveries of BioThrax to allied international governments

International Stem Cell congratulates ACT on the issuance of its recent patent

Premier healthcare alliance recognizes winners of Pinnacle and Performance Awards

Inhalation of gaseous hydrogen sulfide can reduce or prevent lung injury associated with mechanical ventilation

Individuals get involved in alcohol or drug related accidents during summer holidays

Palatin announces completion of patient dosing, database lock in bremelanotide study for ED

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Latest News